The reply.
University of Massachusetts Medical School, Boston, Mass.
Mark S
MS
Klempner
American Lyme Disease Foundation, Lyme, Conn.
Phillip J
PJ
Baker
Departments of Pediatrics, Epidemiology, and Public Health, and Investigative Medicine, Yale University, New Haven, Conn.
Eugene D
ED
Shapiro
National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Md.
Adriana
A
Marques
Division of Allergy, Immunology and Rheumatology, Department of Medicine, New York Medical College, Valhalla, NY.
Raymond J
RJ
Dattwyler
Department of Neurosciences, Overlook Medical Center and Atlantic Neuroscience Institute, Summit, NJ.
John J
JJ
Halperin
Division of Infectious Diseases, Department of Medicine, New York Medical College, Valhalla, NY.
Gary P
GP
Wormser
D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D025065:Borrelia burgdorferi; D006801:Humans; D008193:Lyme Disease / Q000188:drug therapy*
D000900:Anti-Bacterial Agents